Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
Yutaka Matsuda, Brian A. Mendelsohn
Expert Opinion on Biological Therapy (2020) Vol. 21, Iss. 7, pp. 963-975
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Zhiwen Fu, Shijun Li, Sifei Han, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 813
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
Toan D. Nguyen, Brandon M. Bordeau, Joseph P. Balthasar
Cancers (2023) Vol. 15, Iss. 3, pp. 713-713
Open Access | Times Cited: 131
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 558-576
Open Access | Times Cited: 108
Antibody–Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence
Pooja Gogia, Hamza Ashraf, S. Bhasin, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3886-3886
Open Access | Times Cited: 67
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 64
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production
Tomohiro Fujii, Yutaka Matsuda, Takuya Seki, et al.
Bioconjugate Chemistry (2023)
Open Access | Times Cited: 40
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
Julien Dugal‐Tessier, Srinath Thirumalairajan, Nareshkumar Jain
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 838-838
Open Access | Times Cited: 79
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
Othman Al Musaimi, Danah Al Shaer, Fernando Alberício, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 145-145
Open Access | Times Cited: 73
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 54
Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
Zhoujiang Chen, Ranjith Kumar Kankala, Zhiyong Yang, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3719-3746
Open Access | Times Cited: 51
Homogeneous multi-payload antibody–drug conjugates
Toby Journeaux, Gonçalo J. L. Bernardes
Nature Chemistry (2024) Vol. 16, Iss. 6, pp. 854-870
Closed Access | Times Cited: 12
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
Marjorie A. Shapiro
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration
Daniel Yuen, Orlagh M. Feeney, Leo Noi, et al.
ACS Nano (2025)
Closed Access
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Yutaka Matsuda, Brian A. Mendelsohn
Chemical and Pharmaceutical Bulletin (2021) Vol. 69, Iss. 10, pp. 976-983
Open Access | Times Cited: 53
Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody–Drug Conjugates
Yutaka Matsuda, Takuya Seki, Kei Yamada, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 11, pp. 4058-4066
Open Access | Times Cited: 40
Antibody–Drug Conjugate Synthesis Using Continuous Flow Microreactor Technology
Yuichi Nakahara, Brian A. Mendelsohn, Yutaka Matsuda
Organic Process Research & Development (2022) Vol. 26, Iss. 9, pp. 2766-2770
Closed Access | Times Cited: 33
IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review
Chang Yang, Bing He, Hua Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 187-187
Open Access | Times Cited: 15
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production
Tomohiro Fujii, Yutaka Matsuda, Takuya Seki, et al.
(2023)
Open Access | Times Cited: 15
Carbon-Centered Radicals in Protein Manipulation
Xuanxiao Chen, Brian Josephson, Benjamin G. Davis
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 614-638
Open Access | Times Cited: 15
Current approaches for the purification of antibody–drug conjugates
Yutaka Matsuda
Journal of Separation Science (2021) Vol. 45, Iss. 1, pp. 27-37
Closed Access | Times Cited: 37
Tag‐Free Enzymatic Modification for Antibody−Drug Conjugate Production
Shunsuke Yamazaki, Yutaka Matsuda
ChemistrySelect (2022) Vol. 7, Iss. 48
Closed Access | Times Cited: 25
Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
Jianzhong Zhang, Xue Liu, Yutian Xia, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 14
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
Tomohiro Fujii, Yutaka Matsuda
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 11, pp. 1053-1065
Closed Access | Times Cited: 12
Development and Characterization of a Portable Flow Microreactor for Enhanced Bioconjugation Applications
Yuta Endo, Yuichi Nakahara, Ryo Shiroma, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 5, pp. 1806-1813
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top